Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Total Liabilities (2018 - 2026)

Exagen filings provide 9 years of Total Liabilities readings, the most recent being $37.5 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 10.72% to $37.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $37.5 million, a 10.72% increase, with the full-year FY2025 number at $40.6 million, up 15.43% from a year prior.
  • Total Liabilities hit $37.5 million in Q1 2026 for Exagen, down from $40.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $45.9 million in Q1 2022 to a low of $30.7 million in Q3 2024.
  • Median Total Liabilities over the past 5 years was $37.5 million (2026), compared with a mean of $38.0 million.
  • Biggest five-year swings in Total Liabilities: fell 28.82% in 2024 and later surged 45.38% in 2025.
  • Exagen's Total Liabilities stood at $43.8 million in 2022, then fell by 21.73% to $34.2 million in 2023, then rose by 2.62% to $35.1 million in 2024, then rose by 15.43% to $40.6 million in 2025, then fell by 7.51% to $37.5 million in 2026.
  • The last three reported values for Total Liabilities were $37.5 million (Q1 2026), $40.6 million (Q4 2025), and $44.7 million (Q3 2025) per Business Quant data.